Market News AIOpen the app

NexgenRx shared its Q3 2026 results, with revenues up 8% and a big jump in income before taxes.

ResultsRead the original at accessnewswire.com
Good for NXG

NexgenRx grew sales and profit measures in Q3 and over the first 9 months. A $907,728 tax charge caused a $63,993 loss, but the reported business gains support improvement.

NXG · NexgenRx Inc.

AI read · Good for NXG

The AI's read

The tax charge followed the use of the company's remaining past tax losses. That bill caused the reported loss, but sales and profit measures rose in Q3 and across the first 9 months.

Get alerts for NXG

Follow NexgenRx Inc. (NXG) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NXG
Free on the App Store and Google Play, or on the web.